COO (CooperVision) EV/EBITDA Multiple
The current EV/EBITDA multiple demonstrates the resilience of The Cooper Companies (COO), where the value holds at 12.16. This price action confirms that the business is protected by strict FDA regulations and patent law. Stability is further bolstered by the transition of plants to eco-energy to combat plastic use and the deep automation of production lines, which optimizes operating expenses and product sterility quality.
Summary analytical data breakdowns for coopercos.com (COO)
- stock price and consensus target price:
- business market valuation indicators:
- issuer book value statistics:
- debt and liquidity data:
- financial results and valuation multiples details:
COO - Net Income|Projected Future Earnings The Cooper Companies|COO - P/E Multiple|Future Price to Earnings The Cooper Companies|COO - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio CooperSurgical|COO - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) CooperCompanies|COO - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months coopercos.com|COO - Net earnings per share change in current year|Expected earnings per share growth for next year The Cooper Companies
Initial company analysis:CooperVision COO
For The Cooper Companies (COO), which automates the production of lenses and instruments via AI systems, this indicator determines the real value of the business accounting for debt obligations. The metric compares the total enterprise value with operating profit before depreciation and amortization, revealing the efficiency of capital expenditures. Analyzing the trend of the EV/EBITDA multiple allows for the filtering of market noise and an assessment of asset revaluation. This confirms the resilience of high-tech manufacturing amid a rising investment premium.
Competitor analysis for The Cooper Companies
Boston Scientific Inc - Enterprise Value to EBITDA Ratio|EW (Edwards Lifesciences Inc.) - Company Value to Operating Income Before Depreciation Ratio|ResMed Inc. - EV/EBITDA Multiple|Company Value to EBITDA insulet.com|ZBH: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation ALGN|Enterprise Value to EBITDA Ratio GMED|TMDX: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Alphatec Holdings, Inc. (ATEC)|Enterprise Value to EBITDA Ratio artivion.com AORT|EV/EBITDA Multiple ENOV (Enovis)|Integra LifeSciences Corp (IART) - Company Value to EBITDA|Motiva - EV/EBITDA Multiple|BBNX (iLet Bionic Pancreas) - Enterprise Value to Operating Income Before Depreciation|IRMD: EV/EBITDA Multiple|EMBC - Total Company Value to Operating Income Before Depreciation Ratio|TNDM (Tandem Diabetes Care, Inc.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio AxoGen Inc (AXGN)|EV/EBITDA Multiple SIBN|EV/EBITDA Multiple Orthofix Corp (OFIX)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bioventus Inc. BVS|OrthoPediatrics Corp - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TMCI: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation SRTA (Blade Air Mobility)|CARL: EV/EBITDA Multiple|Company Value to EBITDA RxSight Ophthalmic (RXST)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ClearPoint Neuro Inc.|STXS - Enterprise Value to EBITDA Multiple|Enterprise Value to EBITDA Ratio STIM (Neuronetics)|EV/EBITDA Multiple Sight Sciences Inc. (SGHT)|EV/EBITDA Multiple OBIO (Orchestra BioMed)|Total Company Value to Operating Income Before Depreciation Ratio Anika Therapeutics Inc. (ANIK)|NSPR - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio ZJYL|vivani.com (VANI) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Xtant Medical|NMTC (NeuroOne Corp) - EV/EBITDA Multiple|Company Value to EBITDA Modular Med MODD|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Myomo, Inc. (MYO)|envoymedical.com - Enterprise Value to Operating Income Before Depreciation|Vivos Therapeutics, Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio NVNO (enVVeno Medical Corporation)|SINT: Enterprise Value to EBITDA Ratio|Tenon Medical Inc - Enterprise Value to Operating Income Before Depreciation Ratio|LFWD: EV/EBITDA Multiple|Autonomix Medical - Business Value to Operating Income Before Depreciation|IVF (INVO Fertility) - EV/EBITDA Multiple|Company Value to EBITDA Bone Biologics Corp. BBLG|Enterprise Value to EBITDA Ratio AXNX (Axonics Modulation Technologies)|BIOL (Biolase Inc.) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple DYNT (Dynatronics)|FNA - Enterprise Value to EBITDA Ratio|INVO - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
